CervoMed presents neflamapimod DLB trial data at AAIC 2026

Go back to CervoMed presents neflamapimod DLB trial data at AAIC 2026
(NASDAQ: CRVO) Delayed: 2.86 --0 (-0%)
Previous Close $2.86    52 Week High
Open $2.86    52 Week Low
Day High $2.86    P/E N/A 
Day Low $2.86    EPS
Volume 2,630